Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
23.85
0.52 (2.23%)
At close: Aug 18, 2025, 3:59 PM
23.87
0.08%
After-hours: Aug 18, 2025, 04:42 PM EDT
Inhibrx Biosciences Revenue
Inhibrx Biosciences reported an annual revenue of $200K, reflecting a -88.89% growth. For the quarter ending June 30, 2025, Inhibrx Biosciences generated $1.3M in revenue.
Revenue (ttm)
200K
Revenue Growth
-88.89%
Price / Sales Ratio
1114.64
Revenue / Employee
1.28K
Employees
156
Market Cap
345.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 200K | -88.89% |
| Dec 31, 2023 | 1.8M | -17.88% |
| Dec 31, 2022 | 2.19M | -69.24% |
| Dec 31, 2021 | 7.13M | -44.37% |
| Dec 31, 2020 | 12.81M | +40.86% |
| Dec 31, 2019 | 9.09M | +21.24% |
| Dec 31, 2018 | 7.5M | -5.66% |
| Dec 31, 2017 | 7.95M | +19.24% |
| Dec 31, 2016 | 6.67M | n/a |